Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells

Atherosclerosis

Volumn 154, Issue 1, 2001, Pages 31-38

  Stannard, Anita K ^a   Khan, Shabeena ^c   Graham, Annette ^b   Owen, James S ^a   Allen, Sean P ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; E Selectin; Human umbilical vein endothelial cells; Inflammatory cytokines; Vascular cell adhesion molecule 1

Indexed keywords

CELL ADHESION MOLECULE; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL FRACTIONATION; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE RELEASE; DOWN REGULATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0035196582     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00444-5     Document Type: Article

References (51)

1. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
2. Molecular physiology of reverse cholesterol transport
3. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization
4. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
5. HDL, its enzymes and its potential to influence lipid peroxidation
6. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation
7. HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate
8. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
9. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
10. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice
11. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
12. Leukocyte migration and adhesion
13. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions
14. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
15. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1
16. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
17. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
18. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse
19. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
20. Comparative studies on vascular endothelium in vitro. I. Cytokine effects on the expression of adhesion molecules by human umbilical vein, saphenous vein and femoral artery endothelial cells
21. Expression of the CD34 gene in vascular endothelial cells
22. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells
23. Expression of adhesion molecules by Lp(a): A potential novel mechanism for its atherogenicity
24. Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells
25. Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts
26. Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis
27. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells
28. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression
29. Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 beta in human umbilical vein endothelial cells
30. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
31. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells
32. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease
33. Endothelium and acute coronary syndromes
34. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells
35. P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes
36. High density lipoproteins and coronary heart disease
37. Heterogeneity of endothelial cells. Specific markers
38. Locally secreted apolipoprotein (apo)E inhibits vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells
39. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins
40. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells
41. Heparin regulates ICAM-1 expression in human endothelial cells: An example of non-cytokine-mediated endothelial activation
42. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin
43. Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells
44. Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins
45. Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoprotein A-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection
46. Incubation with apolipoprotein A-II markedly induces monocyte adhesion to human aortic endothelial cells
47. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid
48. Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells
49. Apo A-I inhibits foam cell formation in apo E-deficient mice after monocyte adherence to endothelium
50. 2+ transients, adhesion molecule expression and macrophage homing in apoE deficient mice
51. Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice